Integrated ligand and structure-based investigation of structural requirements for silent information regulator activation
Abstract
A series of imidazothiazole and oxazolopyridine derivatives as human silent information regulator (SIRT1) activators were subjected to the integrated 2D and 3D QSAR approaches. The derived 3D QSAR models yielded high cross validated q2 values of 0.682 and 0.628 for CoMFA and CoMSIA respectively. The non-cross validated correlation values of r2training = 0.89; predictive r2test = 0.69 for CoMFA and r2=0.87; predictive r2test =0.67 for CoMSIA reflected the statistical significance of the developed model. The steric, electrostatic, hydrophobic and hydrogen bond acceptor interactions have been found important in describing the variation in human SIRT1 activation. Further, 2D QSAR model for the same dataset yielded high statistical significance and derived 2D models parameters corroborated with 3D model in terms of features. The developed model was also validated through the available active conformation structure of SIRT1. Developed models may be useful for the identification of potential novel human SIRT1 activators as therapeutic agent.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Recombinant SIRT1 expression and SIRT1-METTL3 interaction analysis with computational identification of phytochemical SIRT1 activators and inhibitors
Md Kazy Ebnul Hasan, Md. Nahid Hasan Joy, … Yunyu Shi·bioRxiv·Oct 21, 2026
- Nonallosteric Sirtuin Enzyme Activation: Characterization of Hit Compounds
A. Upadhyay, X. Guan, … R. Chakrabarti·bioRxiv·Apr 17, 2020
- Computationally Driven Discovery and Characterization of SIRT3 Activating Compounds that Fully Recover Catalytic Activity under NAD+ Depletion
X. Guan, A. Upadhyay, … R. Chakrabarti·bioRxiv·Nov 9, 2023
- Mechanism-based sirtuin enzyme activation
X. Guan, A. Upadhyay, … R. Chakrabarti·bioRxiv·Sep 28, 2015
- Discovery of novel compounds as potent activators of Sirt3
C. Reverdy, G. Gitton, … R. Chakrabarti·bioRxiv·Jan 5, 2022
- Development of a QSAR model to predict molecular inhibition of human STAT3
Joshua M. Patterson, Kimberly A. Milligan, Cherese Winstead·bioRxiv·Oct 29, 2021